Brief: Syngene Names Siddharth Mittal As Additional Director, Designated As MD& CEO
March 27 (Reuters) - Syngene International Ltd SYNN.NS: RESIGNATION OF PETER BAINS AS MD & CHIEF EXECUTIVE OFFICER APPOINTED SIDDHARTH MITTAL AS ADDITIONAL DIRECTOR, DESIGNATED AS MD& CEO CHANGE OF ROLE OF KIRAN MAZUMDAR SHAW, FROM NON-EXEC CHAIRPERSON TO EXEC CHAIRPERSON Source text: ID:nnAZN4SNOU4 Further company coverage: SYNN.NS ((Reutersbriefs@thomsonreuters.com;))
Recent news on Syngene International
See all newsIndia's Syngene advances after quarterly profit rebound
Brief: Syngene International Sept-Quarter Consol Profit 322 Million Rupees
India's Syngene International slides to 6-year low on Q1 loss, full-year forecast
Brief: Syngene International Posts June-Quarter Consol Loss 90 Million Rupees
Brief: Syngene International Says Granted Tax Refund Of 86.2 Million Rupees